Dr. Kiss, the finding "casts doubt on the trustworthiness of the bevacizumab currently being compounded for intraocular use by mostly unregulated pharmacies nationwide."

http://www.consultant360.com/story/protein-content-compounded-bevacizumab-varies-considerably